No black box warning on record for 25% Dextrose Infant

As of the latest FDA labeling reviewed, 25% Dextrose Infant (25% DEXTROSE INFANT) does not carry a black box warning. Standard warnings and precautions still apply — see the full 25% Dextrose Infant medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS 25% Dextrose Injection, USP is hypertonic and may cause phlebitis and thrombosis at the site of injection. Significant hyperglycemia and possible hyperosmolar syndrome may result from too rapid administration. The physician should be aware of the symptoms of hyperosmolar syndrome, such as loss of consciousness.

No black box warning on record for 25% Dextrose Infant

Other warnings & precautions

WARNINGS 25% Dextrose Injection, USP is hypertonic and may cause phlebitis and thrombosis at the site of injection. Significant hyperglycemia and possible hyperosmolar syndrome may result from too rapid administration. The physician should be aware of the symptoms of hyperosmolar syndrome, such as loss of consciousness.

25% Dextrose Infant Black Box Warning

No black box warning on record for 25% Dextrose Infant

Other warnings & precautions

25% Dextrose Infant Black Box Warning

No black box warning on record for 25% Dextrose Infant

Other warnings & precautions